Search Videos and More
Interventional Cardiology
Collaboration across interventional cardiology and cardiac surgery creates optimized care plans for each patient—minimizing surgical trauma and recovery time.Cardiac Surgery
Surgeons at the Smidt Heart Institute at Cedars-Sinai work tirelessly to increase the variety of procedures available to patients as well as the array of patients eligible for less invasive techniques.Top-Ranked Smidt Heart Institute at Cedars-Sinai Releases 2024 Annual Report
The Smidt Heart Institute continues to break new ground in cardiovascular research and care. It is a global leader in heart transplants, women's heart disease, targeted therapies, and a suite of minimally invasive procedures.Faculty Publications Dec. 7-14
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Dec. 7-14.Faculty Publications Nov. 30-Dec. 7
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 30-Dec. 7.Lower Back Pain Linked to Subtype of Cells in Spinal “Shock Absorbers"
A new Cedars-Sinai study might have cracked the mystery surrounding the cause of a specific type of back pain.Faculty Publications Nov. 16-30
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 16-30.Faculty Publications Nov. 9-16
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Nov. 9-16.A Stent—And No Stroke—For This Patient
Cedars-Sinai Neurosurgeons Use Minimally Invasive, State-of-the-Art Stenting to Restore Blood Flow to the Brain, Preventing a Debilitating StrokeTreating Pituitary Apoplexy: Medical Management Versus Surgery
Multicenter International Study, Led by Cedars-Sinai, Finds Medical Management Yields Similar Results to SurgeryFaculty Publications Nov. 2-9
This week’s edition of Faculty Publications includes Cedars-Sinai studies that were published Oct. Nov. 2-9.Cedars-Sinai Neurology Chair Honored by National MS Society for COVID-19 Work
Early in the pandemic, patients with multiple sclerosis (MS), an autoimmune disease, were thought to possibly be at higher-than-average risk for COVID-19.